Veli Kairisto - UTU Research Portal

Veli Kairisto

- Docent,
Faculty of Medicine (University of Turku)

velkai@utu.fi

1 of 2

Efficacy of conventional-dose cytarabine, idarubicin and thioguanine versus intermediate-dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long-term results of the prospective randomized nationwide AML-2003 study by the Finnish Leukemia Group (2022)
- European Journal of Haematology
Kolonen Aarne, Sinisalo Marjatta, Huhtala Heini, Rimpiläinen Johanna, Rintala Hannele, Sankelo Marja, Koivunen Elli, Silvennoinen Raija, Räty Riikka, Ruutu Tapani, Volin Liisa, Porkka Kimmo, Jantunen Esa, Nousiainen Tapio, Kuittinen Taru, Penttilä Karri, Pyörälä Marja, Säily Marjaana, Koistinen Pirjo, Kauppila Marjut, Itälä-Remes Maija, Ollikainen Hanna, Rauhala Auvo, Kairisto Veli, Pelliniemi Tarja-Terttu, Elonen Erkki; Finnish Leukemia Group
Gene fusions and oncogenic mutations in MLH1 deficient and BRAFV600E wild-type colorectal cancers (2022)
- Virchows Archiv
Ukkola Iiris, Nummela Pirjo, Kero Mia, Tammio Hanna, Tuominen Jenni, Kairisto Veli, Kallajoki Markku, Haglund Caj, Peltomäki Päivi, Kytölä Soili, Ristimäki Ari
Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study (2022)
- Leukemia
White Helen E., Salmon Matthew, Albano Francesco, Andersen Christina Søs Auður, Balabanov Stefan, Balatzenko Gueorgui, Barbany Gisela, Cayuela Jean-Michel, Cerveira Nuno, Cochaux Pascale, Colomer Dolors, Coriu Daniel, Diamond Joana, Dietz Christian, Dulucq Stéphanie, Engvall Marie, Franke Georg N., Gineikiene-Valentine Egle, Gniot Michal, Gómez-Casares María Teresa, Gottardi Enrico, Hayden Chloe, Hayette Sandrine, Hedblom Andreas, Ilea Anca, Izzo Barbara, Jiménez-Velasco Antonio, Jurcek Tomas, Kairisto Veli, Langabeer Stephen E., Lion Thomas, Meggyesi Nora, Mešanović Semir, Mihok Luboslav, Mitterbauer-Hohendanner Gerlinde, Moeckel Sylvia, Naumann Nicole, Nibourel Olivier, Leibundgut Elisabeth Oppliger, Panayiotidis Panayiotis, Podgornik Helena, Pott Christiane, Rapado Inmaculada, Rose Susan J., Schäfer Vivien, Touloumenidou Tasoula, Veigaard Christopher, Venniker-Punt Bianca, Venturi Claudia, Vigneri Paolo, Vorkinn Ingvild, Wilkinson Elizabeth, Zadro Renata, Zawada Magdalena, Zizkova Hana, Müller Martin C., Saussele Susanne, Ernst Thomas, Polakova Katerina Machova, Hochhaus Andreas, Cross Nicholas C. P.
Tool evaluation for the detection of variably sized indels from next generation whole genome and targeted sequencing data (2022)
- PLoS Computational Biology
Wang Ning, Lysenkov Vladislav, Orte Katri, Kairisto Veli, Aakko Juhani, Khan Sofia, Elo Laura L
Geeniohjatun syövän hoidon työryhmä hoitopäätösten apuna : Läntisen syöpäkeskuksen kokemus (2021)
- Duodecim
Alanne Erika, Orte Katri, Haanpää Maria, Kankuri-Tammilehto Minna, Silvoniemi Maria, Sundvall Maria, Hietanen Sakari, Boström Pia, Laine Jukka, Jaakkola Panu, Minn Heikki, Kallajoki Markku, Kairisto Veli, Elenius Klaus, Vihinen Pia
Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia (2020)
- British Journal of Haematology
Kristian Løvvik Juul‐Dam, Hans B. Ommen, Charlotte G. Nyvold, Christiane Walter, Helen Vålerhaugen , Veli Kairisto, Jonas Abrahamsson, Sofie J. Alm, Kirsi Jahnukainen, Birgitte Lausen, Dirk Reinhardt, Bernward Zeller, Nils von Neuhoff, Linda Fogelstrand, Henrik Hasle
Arpp19 Promotes Myc and Cip2a Expression and Associates with Patient Relapse in Acute Myeloid Leukemia (2019)
- Cancers
Mäkelä E, Löyttyniemi E, Salmenniemi U, Kauko O, Varila T, Kairisto V, Itälä-Remes M, Westermarck J
Hematologisen syöpäpotilaan diagnostinen polku (2019)
- Duodecim
Maija Itälä-Remes, Veli Kairisto
Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (2019)
- Leukemia
T. Sacha, S. Schnittger, T. Touloumenidou, H. Valerhaugen, M. Mueller, F. Pane, L. Rai, C. Damm-Welk, S. Markovic, H. Pfeifer, G. Cazzaniga, V. H. J. van der Velden, J. M. Cayuela, B. Schäfer, O. Spinelli, S. Akiki, S. Avigad, I. Bendit, K. Borg, H. Cavé, L. Elia, S. C. Reshmi, G. Gerrard, S. Hayette, M. Hermanson, A. Juh, T. Jurcek, M. C. Chillón, C. Homburg, G. Martinelli, V. Kairisto, T. Lange, T. Lion, M. C. Mueller, F. Pane, L. Rai, C. Damm-Welk, T. Sacha, S. Schnittger, T. Touloumenidou, H. Valerhaugen, P. Vandenberghe, J. Zuna, H. Serve, E. Herrmann, S. Markovic, J. J. M. van Dongen, O. G. Ottmann
Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial (2018)
- Lancet Oncology
Susanne Saussele, Johan Richter, Joelle Guilhot, Franz X Gruber, Henrik Hjorth-Hansen, Antonio Almeida, Jeroen J W M Janssen, Jiri Mayer, Perttu Koskenvesa, Panayiotis Panayiotidis, Ulla Olsson-Strömberg, Joaquin Martinez-Lopez, Philippe Rousselot, Hanne Vestergaard, Hans Ehrencrona, Veli Kairisto, Katerina Machová Poláková, Martin C Müller, Satu Mustjoki, Marc G Berger, Alice Fabarius, Wolf-Karsten Hofmann, Andreas Hochhaus, Markus Pﬁrrmann, Francois-Xavier Mahon
Measurable Residual Disease Assessment By qPCR in Peripheral Blood Is an Informative Tool for Disease Surveillance in Childhood Acute Myeloid Leukemia (2018)
- Blood
Juul-Dam K, Ommen HB, Nyvold CG, Walter C, Valerhaugen H, Kairisto V, Abrahamsson J, Alm SJ, Jahnukainen K, Lausen B, Reinhardt D, Zeller B, Von Neuhoff N, Fogelstrand L, Hasle H
Syväsekvensoinnilla verisyövän täsmädiagnoosiin ja yksilöllistettyyn hoitoon (2017)
- Kliin lab
Kairisto V
Syväseskvenssoinnilla verisyövän täsmädiagnoosiin ja yksilöllistettyyn hoitoon (2017)
- Kliin lab
Kairisto V
A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR (2015)
- Leukemia
White H, Deprez L, Corbisier P, Hall V, Lin F, Mazoua S, Trapmann S, Aggerholm A, Andrikovics H, Akiki S, Barbany G, Boeckx N, Bench A, Catherwood M, Cayuela JM, Chudleigh S, Clench T, Colomer D, Daraio F, Dulucq S, Farrugia J, Fletcher L, Foroni L, Ganderton R, Gerrard G, Gineikiene E, Hayette S, El Housni H, Izzo B, Jansson M, Johnels P, Jurcek T, Kairisto V, Kizilors A, Kim DW, Lange T, Lion T, Polakova KM, Martinelli G, McCarron S, Merle PA, Milner B, Mitterbauer-Hohendanner G, Nagar M, Nickless G, Nomdedeu J, Nymoen DA, Leibundgut EO, Ozbek U, Pajic T, Pfeifer H, Preudhomme C, Raudsepp K, Romeo G, Sacha T, Talmaci R, Touloumenidou T, Van der Velden VHJ, Waits P, Wang L, Wilkinson E, Wilson G, Wren D, Zadro R, Ziermann J, Zoi K, Mueller MC, Hochhaus A, Schimmel H, Cross NCP, Emons H
Comparative analysis of minimal residual disease detection by multiparameter flow cytometry and enhanced ASO RQ-PCR in multiple myeloma (2014)
- Blood Cancer Journal
R Silvennoinen, T Lundan, V Kairisto, T-T Pelliniemi, M Putkonen, P Anttila, V Huotari, P Mäntymaa, S Siitonen, L Uotila, T-L Penttilä, V Juvonen, T Selander, K Remes
Interim Analysis of a Pan European Stop Tyrosine Kinase Inhibitor Trial in Chronic Myeloid Leukemia : The EURO-SKI study (2014)
- Blood
Mahon FX, Richter J, Guilhot J, Muller MC, Dietz C, Porkka K, Hjorth-Hansen H, Gruber F, Panagoitidis P, Ossenkoppele GJ, Mayer J, Almeida A, Polakova KM, Ehrencrona H, Kairisto V, Berger MG, Stromberg UO, Mustjoki S, Hochhas A, Pfirrmann M, Saussele S
Assessment of molecular remission rate after bortezomib plus dexamethasone induction treatment and autologous stem cell transplantation in newly diagnosed multiple myeloma patients (2013)
- British Journal of Haematology
Silvennoinen R, Kairisto V, Pelliniemi TT, Putkonen M, Anttila P, Saily M, Sikio A, Opas J, Penttila K, Kuittinen T, Honkanen T, Lundan T, Juvonen V, Luukkaala T, Remes K
Establishment of the first World Health Organization international genetic reference panel for quantitation of BCR-ABL mRNA (2010)
- Blood
White HE, Matejtschuk P, Rigsby P, Gabert J, Lin F, Wang YL, Brandford S, Müller MC, Beaufils N, Beillard E, Colomer D, Dvorakova D, Ehrencrona H, Goh H-G, El Housni H, Jones D, Kairisto V et al.
ETS-related gene ERG expression in AML patients is significantly associated with NPM1 mutation status (2010)
- European Journal of Haematology
Hämäläinen M, Juvonen V, Häikiö S, Lakkala T, Johansson J, Pelliniemi T-T, Salmi TT, Remes K, Kairisto V
Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy (2010)
- Blood
Kreutzman A, Juvonen V, Kairisto V, Ekblom M, Stenke L, Seggewiss R, Porkka K, Mustjoki S